( EGR) jumped more than 10% in after-hours trading Thursday as the Costa Mesa, Calif., company swung to a profit of $2.5 million, or 9 cents a share, in the quarter ended Jan. 31. That compares with last year's losses of $4.1 million, or 13 cents a share. Revenue shot up 28% to $92.6 million.
The utility company also boosted its full-year 2007 outlook, now expecting to earn between 11 cents and 14 cents a share. Prior guidance had pegged profits at 2 cents to 7 cents a share. Shares were leaping 18 cents, or 10.4%, to $1.94.
, which sells services to industrial customers, posted fourth-quarter earnings that were 69% higher than last year. The company earned $3.5 million, or 61 cents a share. Sales surged 45% to $79.4 million. Analysts polled by Thomson Financial were looking for 54 cents a share on $76.9 million in revenue. Shares of the Houston-based company were adding $2.89, or 8.8%, to $35.89.
said fourth-quarter earnings came to $4.6 million, or 13 cents a share, compared with $3.5 million, or 11 cents a share, a year ago. Sales added 44% from last year to $48.5 million.
The China-based company, which makes module designs for electronics manufacturers, lifted 2007 guidance as well. Comtech now expects to earn 67 cents a share -- 2 cents more than it did before -- and says its top line will likely range between $210 million and $215 million, up from its earlier prediction of $200 million to $210 million. Shares were up 70 cents, or 4.5%, to $16.20.
( TRMS) slid after the Morrisville, N.C., biotech announced that Dani Bolognesi, chief executive and chief scientific officer, is retiring from those positions effective March 16. In addition, Chief Financial Officer Robert Bonczek will leave on April 30. Bolognesi will remain on the company board until the next annual meeting and serve as scientific consultant to the company through October of next year.
E. Lawrence Hill, the current president of management-services firm Hickey & Hill, will serve as acting president and chief operating officer beginning March 15. Trimeris also announced rising fourth-quarter earnings Thursday, but shares were losing 87 cents, or 8.6%, to $9.20.
widened its fourth-quarter losses to $195.2 million, or $2.07 a share, from $144.5 million, or $1.55 a share, last year. The New York-based company also said park attendance declined by 12% during the quarter, excluding its nonoperational New Orleans park. Shares were off 36 cents, or 5.6%, to $6.12.
sliced its per-share earnings outlook to 14 cents to 17 cents a share on revenue of $29 million to $32 million. The China-based company had previously expected to earn 15 cents to 19 cents a share on sales of $34 million to $37 million. Analysts are seeking per-share income of 17 cents on $36 million in sales. Shares were receding by 59 cents, or 8.3%, to $6.50.
( TLCV), a Canadian laser-eye-surgery outfit, lost ground after profits from operations came to $145,000, or break-even, compared with $423,000, or a penny a share, a year ago. The company's total bottom line reflected a loss of 3 cents a share, burdened heavily by its investment in
( OCCX). This narrowed from nickel-a-share losses last year, but shares were down 29 cents, or 5.5%, to $4.95.